Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Ḧurthle-cell neoplasms of the thyroid

« Previous Next »The American Journal of Surgery
Volume 200, Issue 1 , Pages 41-46, July 2010

Insoo Suh, M.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA
- Corresponding author. Tel.: +1-415-476-1239; fax: +1-415-502-1259
Menno R. Vriens, M.D., Ph.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA
Marlon A. Guerrero, M.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA
Ann Griffin, Ph.D.
- Cancer Center Registry, University of California, San Francisco, CA, USA
Wen T. Shen, M.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA
Quan-Yang Duh, M.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA
Orlo H. Clark, M.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA
Electron Kebebew, M.D.
- Department of Surgery, University of California, San Francisco, 513 Parnassus Ave., Box 0470, San Francisco, CA 94143-0470, USA